Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.

Blood
Hima BansalSwaminathan Padmanabhan

Abstract

The aberrant overexpression of Wilms tumor 1 (WT1) in myeloid leukemia plays an important role in blast cell survival and resistance to chemotherapy. High expression of WT1 is also associated with relapse and shortened disease-free survival in patients. However, the mechanisms by which WT1 expression is regulated in leukemia remain unclear. Here, we report that heat shock protein 90 (Hsp90), which plays a critical role in the folding and maturation of several oncogenic proteins, associates with WT1 protein and stabilizes its expression. Pharmacologic inhibition of Hsp90 resulted in ubiquitination and subsequent proteasome-dependant degradation of WT1. RNAi-mediated silencing of WT1 reduced the survival of leukemia cells and increased the sensitivity of these cells to chemotherapy and Hsp90 inhibition. Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2. Collectively, our studies identify WT1 as a novel Hsp90 client and support the crucial role for the WT1-Hsp90 interaction in maintaining leukemia cell survival. Th...Continue Reading

References

Apr 12, 1996·The Journal of Biological Chemistry·W Bruening, J Pelletier
Dec 24, 1997·Leukemia & Lymphoma·K Pritchard-Jones, L King-Underwood
Mar 7, 1998·The Journal of Biological Chemistry·B D JohnsonD O Toft
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·T ScheibelJ Buchner
Nov 17, 1998·The Journal of Cell Biology·W M ObermannF U Hartl
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·T ScheibelJ Buchner
Aug 7, 1999·The Journal of Biological Chemistry·V ScharnhorstA G Jochemsen
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·J H LaityP E Wright
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniela CilloniUNKNOWN Piedmont Study Group on Myleodysplastic Syndromes
Nov 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Paola FortugnoDario C Altieri
Jun 5, 2004·Trends in Molecular Medicine·Adeela KamalFrancis J Burrows
Aug 3, 2004·Oncogene·Youqi HanMark D Minden
Sep 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yoshihiro OkaHaruo Sugiyama
Sep 22, 2005·Nature Reviews. Cancer·Luke Whitesell, Susan L Lindquist
Dec 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·O M GrbovicN Rosen
Feb 14, 2006·The Journal of Biological Chemistry·Wensheng LiuGokul M Das
Apr 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hélène LapillonneJudith Landman-Parker
May 16, 2006·The Journal of Biological Chemistry·Anwar HossainGrady F Saunders
Jun 8, 2006·Annual Review of Biochemistry·Laurence H Pearl, Chrisostomos Prodromou
Aug 3, 2006·Journal of the National Cancer Institute·Boglarka GyurkoczaDario C Altieri
Sep 5, 2006·Molecular Cell·Cara K VaughanLaurence H Pearl
Sep 22, 2006·Human Molecular Genetics·Peter Hohenstein, Nicholas D Hastie
Mar 16, 2007·Leukemia·L YangM D Minden
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wanping Xu, Len Neckers
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David B SolitHoward I Scher
May 26, 2007·Expert Reviews in Molecular Medicine·Suzie Ariyaratana, David M Loeb
Jun 15, 2007·Expert Reviews in Molecular Medicine·Lucy R Osborne, Carolyn B Mervis
Nov 6, 2007·Biochimica Et Biophysica Acta·Avril A MorrisonMichael R Ladomery
Jan 15, 2008·Drug Discovery Today·David B Solit, Gabriela Chiosis
Jun 7, 2008·Nucleic Acids Research·Mohammad Shahidul MakkiChristoph Englert

❮ Previous
Next ❯

Citations

Mar 20, 2013·Trends in Biochemical Sciences·Alina RöhlJohannes Buchner
Jul 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeshi ShimamuraGeoffrey I Shapiro
Apr 11, 2006·Virology Journal·Robert A SpoonerJ Michael Lord
Jan 15, 2014·Leukemia·H BansalS Bansal
Mar 9, 2012·Expert Opinion on Investigational Drugs·Jonathan How, Karen Yee
Apr 11, 2012·International Journal of Cancer. Journal International Du Cancer·Kevin R KellyJennifer S Carew
Nov 9, 2011·Biochimica Et Biophysica Acta·Komal JhaveriGabriela Chiosis
Dec 20, 2011·Clinical Lymphoma, Myeloma & Leukemia·Tareq Al BaghdadiH Scott Boswell
Apr 12, 2017·Leukemia & Lymphoma·Jichen RuanXiaoqun Zheng
Sep 9, 2018·Investigational New Drugs·Muhammed H RahamanShudong Wang
Dec 21, 2017·Radiation Research·Swaminathan P IyerTej K Pandita
Mar 11, 2020·Nature Communications·Michael DietachmayrFlorian Bassermann
Feb 14, 2019·Journal of Cellular Biochemistry·Wenli XieXiugui Sheng
Oct 19, 2017·Carcinogenesis·Kun Yeong LeeZigang Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Related Papers

Nature Reviews. Cancer
Luke Whitesell, Susan L Lindquist
International Journal of Cancer. Journal International Du Cancer
Jennifer K McCleeseCheryl A London
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Wanping Xu, Len Neckers
Proceedings of the National Academy of Sciences of the United States of America
T ScheibelJohannes Buchner
© 2021 Meta ULC. All rights reserved